The association of gene rearrangement and lymphoma diagnosis: A prospective observational study

Xiaoyan He, Pei Xu, Xianwei Wang, Shuming Jiang, Daoyin Gong, Ning Wu, Xiaoyan He, Pei Xu, Xianwei Wang, Shuming Jiang, Daoyin Gong, Ning Wu

Abstract

Introduction: To investigate the gene rearrangement and mutation of lymphoma biomarkers including (Immunoglobulin H (IgH), Immunoglobulin kappa (IGK), Immunoglobulin lambda (IGL), and TCR) in the lymphoma diagnosis.

Methods and analysis: Paraffin tissue samples from 240 cases diagnosed as suspected lymphoma in the department of pathology, Deyang City People's Hospital from June 2020 to June 2021 will be enrolled. Deoxyribonucleic acid extraction and Polymerase Chain Reaction (PCR) amplification will be performed in these paraffin tissue samples. Immunoglobulin and T cell receptor (TCR) rearrangement will be analyzed by hetero-double chain gel electrophoresis and BioMed-2 standardized immunoglobulin gene rearrangement detection system. In this study protocol IGH gene rearrangement, IGK gene rearrangement, both IGH and IGL gene rearrangement, both IGH and IGK gene rearrangement, both IGK and IGL gene rearrangement, both IGH, IGK and IGL gene rearrangement, TCR gene rearrangement and positive Ig/TCR rearrangement will be analyzed.

Discussion: In this study, we will use B and T cell lymphoma analysis focusing on IgH, IGK, IGL, and TCR gene rearrangement, so as to provide early guidance for the diagnosis of lymphoma. Second generation sequencing technology is helpful in the differential diagnosis of lymphoma.

Trial registration: Chinese Clinical trial registry: ChiCTR2000032366.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Flowers CR, Armitage JO. A decade of progress in lymphoma: advances and continuing challenges. Clin Lymphoma Myeloma Leuk 2010;10:414–23.
    1. Vargo JA, Gill BS, Balasubramani GK, et al. Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: do we still need consolidative radiotherapy. J Clin Oncol 2015;33:3710–7.
    1. Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma—treatment approaches in the molecular era. Nat Rev Clin Oncol 2014;11:12–23.
    1. Liu H, Bench AJ, Bacon CM, et al. A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B-and T-cell clonality in diagnostic haematopathology. Br J Haematol 2007;138:31–43.
    1. Coiffier B, Lepage E, Brière J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235–42.
    1. van der Burg M, Tümkaya T, Boerma M, et al. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood 2001;97:1001–8.
    1. Nguyen JT, Kini AR, Li Y, et al. Analysis of immunoglobulin heavy chain rearrangement in a child with recurrent Burkitt lymphoma to determine clonality. J Pediatr Hematol Oncol 2014;36:e125–7.
    1. van Krieken JHJM, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2006;21:201–6.
    1. Ohshima K, Kikuchi M, Shibata T, et al. Clonal analysis of Hodgkin's disease shows absence of TCR/Ig gene rearrangement, compared with T-cell-rich B-cell lymphoma and incipient adult T-cell leukemia/lymphoma. Leuk Lymphoma 1994;15:469–79.
    1. Patel KP, Pan Q, Wang Y, et al. Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements. J Mol Diagn 2010;12:226–37.
    1. Marini O, Spina C, Mimiola E, et al. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget 2016;7:27676–88.
    1. Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol 2014;11:12–23.
    1. Lee G-W, Go S-I, Kim S-H, et al. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma. Leuk Lymphoma 2015;56:1020–6.
    1. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–11.
    1. Morin RD, Mungall K, Pleasance E, et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood 2013;122:1256–65.
    1. Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 2010;116:e90–8.
    1. Pasqualucci LRD-F. Genetics of diffuse large B-cell lymphoma. Blood 2018;131:2307.
    1. Zhang Y, Peng X, Tang Y, et al. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein–Barr virus-associated lymphomas. J Med Virol 2016;88:1804–13.
    1. Khalil SH, Hamadah IR. The applicability of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for cutaneous T-cell lymphoma. Saudi Med J 2006;27:951–4.
    1. Bo J, Sun L, Wang W, et al. Novel diagnostic biomarker for patients with Non-Hodgkin's Lymphoma by IgH gene rearrangement. J Cancer Res Ther 2016;12:903–8.
    1. Sinkora M, Sinkorova J, Stepanova K. Ig light chain precedes heavy chain gene rearrangement during development of B cells in swine. J Immunol 2017;198:1543–52.
    1. Sigvardsson M. Molecular regulation of differentiation in early Blymphocyte development. Int J Mol Sci 2018;19:1928.
    1. Schroeder HW, Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010;125:S41–52.
    1. Petrova VN, Muir L, McKay PF, et al. Combined influence of B-cell receptor rearrangement and somatic hypermutation on B-cell class-switch fate in health and in chronic lymphocytic leukemia. Front Immunol 2018;9:1784.
    1. Miller JE, Wilson SS, Jaye DL, et al. An automated semiquantitative B and T cell clonality assay. Mol Diagn 1999;4:101–17.
    1. Liao Y-L, Chang S-T, Kuo S-Y, et al. Angioimmunoblastic T-cell lymphoma of cytotoxic T-cell phenotype containing a large B-cell proliferation with an undersized B-cell clonal product. Appl Immunohistochem Mol Morphol 2010;18:185–9.
    1. Nam-Cha S, San-Millán B, Mollejo M, et al. Light-chain-restricted germinal centres in reactive lymphadenitis: report of eight cases. Histopathology 2008;52:436–44.
    1. Van Dongen J, Langerak A, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257–317.
    1. Evans P, Pott C, Groenen P, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007;21:207–14.
    1. Dik WA, Pike-Overzet K, Weerkamp F, et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 2005;201:1715–23.
    1. Huang W, Qiu T, Zeng L, et al. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms. Oncotarget 2016;7:78355–78362.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅